ABVC BioPharma, Inc. Investments, Fair Value Disclosure
ABVC BioPharma, Inc. (ABVC) had Investments, Fair Value Disclosure of TWD 25.02 million as of 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Notes
us-gaap:InvestmentsFairValueDisclosure · last filed 2026-03-03
- 2025-12-31: Investments, Fair Value Disclosure 25.02M TWD.
TWD
| Period end | Investments, Fair Value Disclosure |
|---|---|
| 2025-12-31 | 25.02M TWD 10-K · filed 2026-03-03 |
USD
| Period end | Investments, Fair Value Disclosure |
|---|---|
| 2025-12-31 | $803.01K 10-K · filed 2026-03-03 |